JP2008540484A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540484A5 JP2008540484A5 JP2008510532A JP2008510532A JP2008540484A5 JP 2008540484 A5 JP2008540484 A5 JP 2008540484A5 JP 2008510532 A JP2008510532 A JP 2008510532A JP 2008510532 A JP2008510532 A JP 2008510532A JP 2008540484 A5 JP2008540484 A5 JP 2008540484A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- oil
- weight
- pharmaceutical composition
- fatty acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 4
- 229930195729 fatty acid Natural products 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- 150000004665 fatty acids Chemical class 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000000839 emulsion Substances 0.000 claims 2
- 230000001613 neoplastic effect Effects 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000002622 anti-tumorigenesis Effects 0.000 claims 1
- 201000000220 brain stem cancer Diseases 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 201000007455 central nervous system cancer Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 201000002313 intestinal cancer Diseases 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 230000002601 intratumoral effect Effects 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 208000029255 peripheral nervous system cancer Diseases 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200501141A ES2264886B1 (es) | 2005-05-12 | 2005-05-12 | Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales. |
| ESP-200501141 | 2005-05-12 | ||
| PCT/EP2006/061833 WO2006120120A1 (en) | 2005-05-12 | 2006-04-26 | Use of docosahexaenoic glycerides for the treatment of tumorous diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014128247A Division JP6038841B2 (ja) | 2005-05-12 | 2014-06-23 | 腫瘍性疾患の治療のためのドコサヘキサエン酸グリセリドの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008540484A JP2008540484A (ja) | 2008-11-20 |
| JP2008540484A5 true JP2008540484A5 (enExample) | 2009-06-18 |
| JP5893235B2 JP5893235B2 (ja) | 2016-03-23 |
Family
ID=36809521
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008510532A Active JP5893235B2 (ja) | 2005-05-12 | 2006-04-26 | 腫瘍性疾患の治療のためのドコサヘキサエン酸グリセリドの使用 |
| JP2014128247A Active JP6038841B2 (ja) | 2005-05-12 | 2014-06-23 | 腫瘍性疾患の治療のためのドコサヘキサエン酸グリセリドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014128247A Active JP6038841B2 (ja) | 2005-05-12 | 2014-06-23 | 腫瘍性疾患の治療のためのドコサヘキサエン酸グリセリドの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20080207947A1 (enExample) |
| EP (1) | EP1881824B1 (enExample) |
| JP (2) | JP5893235B2 (enExample) |
| CA (1) | CA2614192C (enExample) |
| DK (1) | DK1881824T3 (enExample) |
| ES (2) | ES2264886B1 (enExample) |
| IL (1) | IL187274A (enExample) |
| NO (1) | NO336953B1 (enExample) |
| NZ (1) | NZ563301A (enExample) |
| PL (1) | PL1881824T3 (enExample) |
| PT (1) | PT1881824E (enExample) |
| WO (1) | WO2006120120A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2264886B1 (es) * | 2005-05-12 | 2008-02-01 | Proyecto Empresarial Brudy, S.L. | Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales. |
| CN101262863B (zh) * | 2005-07-08 | 2016-08-31 | Dsmip资产公司 | 用于治疗痴呆和前痴呆相关病症的多不饱和脂肪酸 |
| ES2277557B1 (es) | 2005-12-21 | 2008-07-01 | Proyecto Empresarial Brudy, S.L. | Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo. |
| KR101256448B1 (ko) | 2005-12-21 | 2013-04-19 | 브루디 테크놀로지 에스엘 | 세포의 산화적 손상과 연관된 병리상태를 치료하기 위한ｄｈａ, ｅｐａ 또는 ｄｈａ 유래의 ｅｐａ의 용도 |
| US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| CA2708679C (en) * | 2007-12-19 | 2016-11-15 | Prometic Biosciences Inc. | Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| WO2011103514A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha triglyceride emulsions |
| US20110200645A1 (en) * | 2010-02-18 | 2011-08-18 | Martek Biosciences Corporation | DHA Free Fatty Acid Emulsions |
| WO2011103510A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha ester emulsions |
| EP2599485B1 (en) * | 2010-07-26 | 2019-02-20 | FUJIFILM Corporation | Fat-containing composition and oral formulation containing same |
| ES2753387T3 (es) | 2013-04-22 | 2020-04-08 | Smartfish As | Uso de una composición que comprende aceite de pescado y zumo para el tratamiento y/o tratamiento posterior del cáncer |
| KR101665253B1 (ko) | 2015-06-19 | 2016-10-25 | 순천향대학교 산학협력단 | 도코사헥사에노산 및 트리아신 씨를 포함하는 것을 특징으로 하는 자궁내막암 치료 및 예방용 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3721137A1 (de) * | 1987-06-26 | 1989-01-05 | Dietl Hans | Fettemulsion zur intravenoesen anwendung |
| US5147854A (en) * | 1990-05-22 | 1992-09-15 | Hoffmann-La Roche Inc. | Tgf-b compositions and method |
| JP2572692B2 (ja) * | 1991-07-24 | 1997-01-16 | ボーソー油脂 株式会社 | ドコサヘキサエン酸トリグリセリドの製造法 |
| JPH05139968A (ja) * | 1991-11-14 | 1993-06-08 | Sagami Chem Res Center | メダラシン活性促進剤 |
| JPH0616548A (ja) * | 1992-06-30 | 1994-01-25 | Sagami Chem Res Center | 組織異常増殖抑制剤 |
| JPH06116585A (ja) * | 1992-10-09 | 1994-04-26 | Kanegafuchi Chem Ind Co Ltd | 油脂の精製方法 |
| JP3526632B2 (ja) * | 1994-08-22 | 2004-05-17 | 旭化成ケミカルズ株式会社 | 高度不飽和脂肪酸含有油脂 |
| JPH1057086A (ja) * | 1996-08-20 | 1998-03-03 | Asahi Chem Ind Co Ltd | 高濃度ドコサヘキサエン酸モノグリセリドの製造方法 |
| AU5928599A (en) * | 1999-09-09 | 2001-04-10 | Efa Sciences Llc. | Methods for treating cell proliferative disorders including cancer |
| JP2002180082A (ja) * | 2000-12-11 | 2002-06-26 | Maruha Corp | 摂取物 |
| US20040052837A1 (en) * | 2002-06-27 | 2004-03-18 | William Stillwell | Lipid conjugated anti-cancer drugs and methods of use thereof |
| ES2264886B1 (es) * | 2005-05-12 | 2008-02-01 | Proyecto Empresarial Brudy, S.L. | Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales. |
-
2005
- 2005-05-12 ES ES200501141A patent/ES2264886B1/es not_active Expired - Lifetime
-
2006
- 2006-04-26 NZ NZ563301A patent/NZ563301A/en not_active IP Right Cessation
- 2006-04-26 PL PL06754856T patent/PL1881824T3/pl unknown
- 2006-04-26 WO PCT/EP2006/061833 patent/WO2006120120A1/en not_active Ceased
- 2006-04-26 EP EP06754856.0A patent/EP1881824B1/en active Active
- 2006-04-26 PT PT06754856T patent/PT1881824E/pt unknown
- 2006-04-26 ES ES06754856.0T patent/ES2531599T3/es active Active
- 2006-04-26 JP JP2008510532A patent/JP5893235B2/ja active Active
- 2006-04-26 CA CA2614192A patent/CA2614192C/en not_active Expired - Fee Related
- 2006-04-26 DK DK06754856.0T patent/DK1881824T3/en active
- 2006-04-26 US US11/913,994 patent/US20080207947A1/en not_active Abandoned
-
2007
- 2007-11-08 IL IL187274A patent/IL187274A/en active IP Right Grant
- 2007-12-11 NO NO20076382A patent/NO336953B1/no not_active IP Right Cessation
-
2009
- 2009-08-31 US US12/550,780 patent/US9271954B2/en active Active
-
2014
- 2014-06-23 JP JP2014128247A patent/JP6038841B2/ja active Active
-
2016
- 2016-01-25 US US15/005,181 patent/US20170333381A9/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brown et al. | Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators | |
| SMT201300095B (it) | Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia | |
| JP2008540484A5 (enExample) | ||
| ES2613606T3 (es) | Uso de derivados de ácidos grasos polinsaturados como medicamentos | |
| NO20076382L (no) | Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer | |
| NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| JP2010195825A5 (enExample) | ||
| MX378496B (es) | Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina. | |
| JP2015143248A5 (enExample) | ||
| JP2013521310A5 (enExample) | ||
| JP2013520454A5 (enExample) | ||
| EP3682875A3 (en) | Methods of treating pediatric metabolic syndrome | |
| El-Ansary et al. | Relative abundance of short chain and polyunsaturated fatty acids in propionic acid-induced autistic features in rat pups as potential markers in autism | |
| CN102843922A (zh) | 硝基脂肪酸–认知减退的神经保护和/或抑制 | |
| HRP20200394T1 (hr) | Smjesa masnih kiselina (gmk, grupa masnih kiselina) za primjenu u liječenju inflamatornih patologija | |
| JP2013537192A (ja) | 非経口投与治療薬物ビークルとしてオメガ−３脂肪酸を用いる薬物有害事象の軽減方法 | |
| CN104968330A (zh) | 用于治疗剧痛的组合物及方法 | |
| JP2014515408A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| WO2012049227A3 (en) | Novel omega-3 and omega-6 fatty acid compositions and uses thereof | |
| JP2007518764A (ja) | 中枢神経系障害の治療のための、選択されたｎ−３系脂肪酸の高度濃縮組成物の使用 | |
| JP2017523230A5 (enExample) | ||
| IL250271B2 (en) | A mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies | |
| MX2012008081A (es) | Composiciones que comprenden extractos de andrographis paniculata y ginkgo biloba combinados con fosfolipidos. | |
| JP2012511510A5 (enExample) |